...
首页> 外文期刊>Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy >High low-density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions
【24h】

High low-density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions

机译:高密度脂蛋白胆固醇作为血液透析患者经皮冠状动脉干预的血液透析患者冠心病患者的独立危险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

HD patients have been reported to have a higher risk of restenosis after percutaneous coronary intervention (PCI). The aim of this study was to investigate the risk factors of coronary restenosis in HD patients. We enrolled 54 HD patients (mean age: 66.5 +/- 10.1 years; 72.2% men; mean HD duration: 3.7 years), who received PCI and follow-up coronary angiography. Of the patients, 22 (40.7%) had restenosis within 3 to 12 months of PCI. Univariate logistic analysis showed low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio, LDL-C, non-HDL-C, and history of major adverse cardiovascular events were significantly associated with coronary restenosis (OR]: 1.89, 1.27, 1.22, and 5.79, respectively). Multivariate analysis showed that LDL-C was significantly associated with coronary restenosis (OR: 1.43). These data suggest that LDL-C is an independent risk factor for coronary restenosis in HD patients undergoing PCI, and strict lipid management may be required.
机译:据报道,HD患者经皮冠状动脉介入治疗(PCI)后再狭窄的风险较高。本研究旨在探讨HD患者冠状动脉再狭窄的危险因素。我们招募了54名接受PCI和后续冠状动脉造影的HD患者(平均年龄:66.5+/-10.1岁;72.2%的男性;平均HD持续时间:3.7年)。其中22例(40.7%)在PCI术后3至12个月内发生再狭窄。单变量logistic分析显示,低密度脂蛋白胆固醇(LDL-C)/高密度脂蛋白胆固醇(HDL-C)比值、LDL-C、非HDL-C和主要不良心血管事件史与冠状动脉再狭窄显著相关(OR):分别为1.89、1.27、1.22和5.79。多变量分析显示LDL-C与冠状动脉再狭窄显著相关(OR:1.43)。这些数据表明,LDL-C是接受PCI的HD患者冠状动脉再狭窄的独立危险因素,可能需要严格的脂质管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号